Fractionated high dose rate brachytherapy moulds--a precise treatment for carcinoma of the pinna.
Pye, David A
Collins, Conor D
Perry, Lesley A
Wilkinson, John M
AffiliationDepartment of Clinical Oncology, Christie Hospital, Withington, Manchester, UK.
MetadataShow full item record
AbstractBACKGROUND AND PURPOSE: The aim of this paper is to describe a fractionated high dose rate brachytherapy procedure for the treatment of small superficial cancers of the pinna and to report the outcome in a small series of patients. MATERIALS AND METHODS: Thirteen patients with superficial cancers of the pinna, not invading cartilage, have been treated and in the majority of cases the tumour thickness was determined by a transdermal ultrasound measurement. For the single-plane moulds the prescribed surface dose was 45 Gy in eight fractions over 5 days and the moulds were constructed such that the full thickness of the disease, as determined by the ultrasound measurement, would lie within the 80% isodose surface. One case was treated with a sandwich mould and in this case the dose was reduced to 42.5 Gy. The treatment machine was a high dose rate microselectron, which contains a single stepping iridium source. RESULTS: The radiation reactions were of moderate severity, but were limited to the high dose volume. In all cases there was complete tumour resolution and rapid healing occurred leaving a barely perceptible scar. There were no recurrences over a minimum follow-up time of 18 months and there were no late radiation complications in this period. CONCLUSIONS: The treatment of superficial carcinoma of the pinna by means of HDR moulds is a safe and reliable technique. In this small series of patients there was total tumour control with excellent cosmesis.
CitationFractionated high dose rate brachytherapy moulds--a precise treatment for carcinoma of the pinna. 1998, 48 (3):277-81 Radiother Oncol
JournalRadiotherapy and Oncology
- Definitive radiotherapy based on HDR brachytherapy with iridium 192 in uterine cervix carcinoma: report on the Vienna University Hospital findings (1993-1997) compared to the preceding period in the context of ICRU 38 recommendations.
- Authors: Pötter R, Knocke TH, Fellner C, Baldass M, Reinthaller A, Kucera H
- Issue date: 2000 Mar-Apr
- High-dose-rate brachytherapy in the treatment of uterine cervix cancer. Analysis of dose effectiveness and late complications.
- Authors: Ferrigno R, dos Santos Novaes PE, Pellizzon AC, Maia MA, Fogarolli RC, Gentil AC, Salvajoli JV
- Issue date: 2001 Aug 1
- [Early-stage carcinoma of the external auditory canal treated by intracavitary irradiation with HDR 192Ir-RALS: a case report].
- Authors: Suzuki G, Hayabuchi N, Kurata S, Aoki M, Nakashima T
- Issue date: 2004 Sep
- Interstitial high-dose-rate brachytherapy boost: the feasibility and cosmetic outcome of a fractionated outpatient delivery scheme.
- Authors: Manning MA, Arthur DW, Schmidt-Ullrich RK, Arnfield MR, Amir C, Zwicker RD
- Issue date: 2000 Dec 1
- Acute genitourinary toxicity after high-dose-rate (HDR) brachytherapy combined with hypofractionated external-beam radiation therapy for localized prostate cancer: correlation between the urethral dose in HDR brachytherapy and the severity of acute genitourinary toxicity.
- Authors: Akimoto T, Ito K, Saitoh J, Noda SE, Harashima K, Sakurai H, Nakayama Y, Yamamoto T, Suzuki K, Nakano T, Niibe H
- Issue date: 2005 Oct 1